TY - JOUR
T1 - Browning of human adipocytes requires KLF11 and reprogramming of PPARγ superenhancers
AU - Loft, Anne
AU - Forss, Isabel
AU - Siersbæk, Majken Storm
AU - Schmidt, Søren Fisker
AU - Larsen, Ann Sofie Bøgh
AU - Madsen, Jesper Grud Skat
AU - Pisani, Didier F.
AU - Nielsen, Ronni
AU - Aagaard, Mads Malik
AU - Mathison, Angela
AU - Neville, Matt J.
AU - Urrutia, Raul
AU - Karpe, Fredrik
AU - Amri, Ez Zoubir
AU - Mandrup, Susanne
N1 - Publisher Copyright:
© 2015 Loft et al.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Long-term exposure to peroxisome proliferator-activated receptor g (PPARg) agonists such as rosiglitazone induces browning of rodent and human adipocytes; however, the transcriptional mechanisms governing this phenotypic switch in adipocytes are largely unknown. Here we show that rosiglitazone-induced browning of human adipocytes activates a comprehensive gene program that leads to increased mitochondrial oxidative capacity. Once induced, this gene program and oxidative capacity are maintained independently of rosiglitazone, suggesting that additional browning factors are activated. Browning triggers reprogramming of PPARg binding, leading to the formation of PPARg ‘‘superenhancers’’ that are selective for brown-in-white (brite) adipocytes.These are highly associated with key brite-selective genes. Based on such an association, we identified an evolutionarily conserved metabolic regulator, Kruppel-like factor 11 (KLF11), as a novel browning transcription factor in human adipocytes that is required for rosiglitazone-induced browning, including the increase in mitochondrial oxidative capacity. KLF11 is directly induced by PPARg and appears to cooperate with PPARg in a feed-forward manner to activate and maintain the brite-selective gene program.
AB - Long-term exposure to peroxisome proliferator-activated receptor g (PPARg) agonists such as rosiglitazone induces browning of rodent and human adipocytes; however, the transcriptional mechanisms governing this phenotypic switch in adipocytes are largely unknown. Here we show that rosiglitazone-induced browning of human adipocytes activates a comprehensive gene program that leads to increased mitochondrial oxidative capacity. Once induced, this gene program and oxidative capacity are maintained independently of rosiglitazone, suggesting that additional browning factors are activated. Browning triggers reprogramming of PPARg binding, leading to the formation of PPARg ‘‘superenhancers’’ that are selective for brown-in-white (brite) adipocytes.These are highly associated with key brite-selective genes. Based on such an association, we identified an evolutionarily conserved metabolic regulator, Kruppel-like factor 11 (KLF11), as a novel browning transcription factor in human adipocytes that is required for rosiglitazone-induced browning, including the increase in mitochondrial oxidative capacity. KLF11 is directly induced by PPARg and appears to cooperate with PPARg in a feed-forward manner to activate and maintain the brite-selective gene program.
KW - Browning of human adipocytes
KW - Genomic reprogramming
KW - KLF11
KW - PPARγ
KW - Rosiglitazone
KW - Superenhancer
UR - http://www.scopus.com/inward/record.url?scp=84920403959&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84920403959&partnerID=8YFLogxK
U2 - 10.1101/gad.250829.114
DO - 10.1101/gad.250829.114
M3 - Article
C2 - 25504365
AN - SCOPUS:84920403959
SN - 0890-9369
VL - 29
SP - 7
EP - 22
JO - Genes and Development
JF - Genes and Development
IS - 1
ER -